Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 171

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

SREBPs: sterol-regulated transcription factors

Espenshade, Peter J. · 2006 · Journal of Cell Science

Abstract

Studies of the feedback regulation of cholesterol synthesis in animals have led to the identification of a unique family of membrane-bound transcription factors, sterol regulatory element binding proteins (SREBPs) (Brown and Goldstein, 1997). In the presence of cholesterol, SREBPs are sequestered in the endoplasmic reticulum (ER). In the absence of a sterol signal, however, SREBPs undergo specific proteolytic events that lead to activation of distinct sets of target genes that control lipid metabolism. Characterization of this sterol-regulated pathway has revealed new paradigms for metabolic signal transduction.Transcription of LDL receptor and genes required for cholesterol and fatty acid synthesis are controlled by membrane-bound transcription factors called SREBPs (Horton et al., 2002). The N-terminal domain of SREBP is a basic helix-loop-helix leucine zipper transcription factor. The C-terminus forms a tight complex with SREBP-cleavage-activating protein (Scap), which functions as the sterol sensor in this system. Two genes encode three SREBP isoforms (∼1150 residues): SREBP-1a, SREBP-1c/ADD1 and SREBP-2 (Tontonoz et al., 1993; Brown and Goldstein, 1997). The predominant forms in the liver are SREBP-2 and SREBP-1c/ADD1, which preferentially regulate genes involved in sterol biosynthesis and fatty acid synthesis, respectively (Horton et al., 2002). SREBP-1a activates all SREBP-responsive genes. To date, SREBPs are known to enhance directly transcription of more than 30 genes needed for uptake and synthesis of cholesterol, fatty acids, triglycerides, and phospholipids (Horton et al., 2003). Despite acting in diverse biosynthetic pathways, the activity of each SREBP isoform is regulated by sterols and Scap (Matsuda et al., 2001). This mechanism is shown in the poster.In sterol-replete cells, Scap binds to cholesterol in the ER membrane and assumes a conformation that promotes binding to the ER-resident protein Insig (for insulin-induced gene) (Peng et al., 1997). This retains the SREBP-Scap complex in the ER by preventing interaction of Scap with the COPII vesicle-formation proteins Sar1, Sec23 and Sec24 (Rawson, 2003). In sterol-depleted cells, binding to Insig is disrupted and SREBP-Scap is sorted in COPII-coated transport vesicles. Scap then escorts SREBP to the Golgi, where two sequential proteolytic cleavage events, mediated by the site 1 (S1P) and site 2 (S2P) proteases, release the N-terminal transcription factor domain from the membrane (Rawson, 2003). Released SREBP is transported into the nucleus as a dimer by importin β through interactions with the helix-loop-helix domain (Lee et al., 2003). In the nucleus, SREBP activates transcription by binding to sterol regulatory element (SRE) sequences in the promoters of target genes. The resultant increase in synthesis and uptake of cholesterol then feeds back to inhibit activation of SREBP. Finally, nuclear residence of SREBPs is limited by ubiquitin-dependent proteasomal degradation.Scap (1278 residues) contains two functional domains: the N-terminus consists of eight transmembrane segments and the C-terminus contains multiple WD repeats that mediate binding to SREBP. Genetic and biochemical experiments define transmembrane segments 2-6 (TM2-TM6) of Scap as a sterol-sensing domain. Point mutations in TM2-TM6 (Y298C, L315F or D443N) prevent binding of Scap to Insig, resulting in constitutive ER-to-Golgi transport of SREBP-Scap that is resistant to sterol inhibition (Rawson, 2003). In addition, recombinant Scap TM1-TM8 binds to cholesterol in vitro and undergoes a cholesterol-dependent conformational change (Brown et al., 2002; Radhakrishnan et al., 2004). In the absence of sterols, Scap forms a complex with the COPII cargo-selection proteins Sec23 and Sec24 (Espenshade et al., 2002; Antonny and Schekman, 2001). COPII binding requires the sequence MELADL between TM6 and TM7 in Scap, whereas sterol inhibition of COPII binding requires Insig (Sun et al., 2005).Interestingly, HMG-CoA reductase, which catalyzes the first committed step in sterol synthesis, also contains a sterol-sensing domain and is negatively regulated by binding to Insig (Sever et al., 2003). However, in the case of HMG-CoA reductase, sterol-regulated binding to Insig accelerates ubiquitylation and proteasomal degradation of the enzyme (Song et al., 2005). Sterol-sensing domains are also found in other proteins, such as the Neimann-Pick type C disease gene NPC1 and the Hedgehog receptor Patched. However, the role of Insig in regulation of these proteins remains to be tested (Kuwabara and Labouesse, 2002).Insigs are ER-resident proteins that contain six transmembrane segments and negatively regulate Scap and HMG-CoA reductase (Yang et al., 2002). Humans have two proteins, Insig-1 (277 aa) and Insig-2 (225 aa), that differ in the length of their cytosolic N-termini (Yabe et al., 2002). Studies using mice and cultured cells lacking Insig-1 as well as Insig-2 demonstrate that they are essent

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/jcs.02866

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Espenshade, P. J.
Venue
Journal of Cell Science
Published
2006-03-15
Volume
119
Issue
6
Pages
973-976
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2110646266
Cited by
171
References
5
FWCI
11.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.